IONS - Ionis Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue507,666346,620283,703214,161
Cost of Revenue374,244342,023321,192240,446
Gross Profit133,4224,597-37,489-26,285
Operating Expenses
Research Development374,644374,644374,644374,644
Selling General and Administrative108,48848,61637,17320,140
Non Recurring----
Others----
Total Operating Expenses482,732390,639358,365260,586
Operating Income or Loss24,934-44,019-74,662-46,425
Income from Continuing Operations
Total Other Income/Expenses Net-51,758-39,603-13,244-7,966
Earnings Before Interest and Taxes24,934-44,019-74,662-46,425
Interest Expense-44,752-38,795-36,732-22,209
Income Before Tax-23,276-83,622-87,906-54,391
Income Tax Expense-5,9802,934372-15,407
Minority Interest87,84787,84787,84787,847
Net Income From Continuing Ops-17,296-86,556-88,278-38,984
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,970-86,556-88,278-38,984
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,970-86,556-88,278-38,984